Literature DB >> 20516114

Molecular causes for BUBR1 dysfunction in the human cancer predisposition syndrome mosaic variegated aneuploidy.

Saskia J E Suijkerbuijk1, Maria H J van Osch, Frank L Bos, Sandra Hanks, Nazneen Rahman, Geert J P L Kops.   

Abstract

Genetic mutations in the mitotic regulatory kinase BUBR1 are associated with the cancer-susceptible disorder mosaic variegated aneuploidy (MVA). In patients with biallelic mutations, a missense mutation pairs with a truncating mutation. Here, we show that cell lines derived from MVA patients with biallelic mutations have an impaired mitotic checkpoint, chromosome alignment defects, and low overall BUBR1 abundance. Ectopic expression of BUBR1 restored mitotic checkpoint activity, proving that BUBR1 dysfunction causes chromosome segregation errors in the patients. Combined analysis of patient cells and functional protein replacement shows that all MVA mutations fall in two distinct classes: those that impose specific defects in checkpoint activity or microtubule attachment and those that lower BUBR1 protein abundance. Low protein abundance is the direct result of the absence of transcripts from truncating mutants combined with high protein turnover of missense mutants. In this group of missense mutants, the amino acid change consistently occurs in or near the BUBR1 kinase domain. Our findings provide a molecular explanation for chromosomal instability in patients with biallelic genetic mutations in BUBR1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516114      PMCID: PMC2887387          DOI: 10.1158/0008-5472.CAN-09-4319

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments.

Authors:  Michael A Lampson; Tarun M Kapoor
Journal:  Nat Cell Biol       Date:  2004-12-12       Impact factor: 28.824

Review 2.  Process or perish: quality control in mRNA biogenesis.

Authors:  Milo B Fasken; Anita H Corbett
Journal:  Nat Struct Mol Biol       Date:  2005-06       Impact factor: 15.369

3.  Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome.

Authors:  Shinya Matsuura; Yoshiyuki Matsumoto; Ken-ichi Morishima; Hideki Izumi; Hiroshi Matsumoto; Emi Ito; Keisuke Tsutsui; Junya Kobayashi; Hiroshi Tauchi; Yoshinori Kajiwara; Seiji Hama; Kaoru Kurisu; Hidetoshi Tahara; Mitsuo Oshimura; Kenshi Komatsu; Tatsuro Ikeuchi; Tadashi Kajii
Journal:  Am J Med Genet A       Date:  2006-02-15       Impact factor: 2.802

Review 4.  Does aneuploidy cause cancer?

Authors:  Beth A A Weaver; Don W Cleveland
Journal:  Curr Opin Cell Biol       Date:  2006-10-12       Impact factor: 8.382

5.  S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.

Authors:  Dimitrios A Skoufias; Salvatore DeBonis; Yasmina Saoudi; Luc Lebeau; Isabelle Crevel; Robert Cross; Richard H Wade; David Hackney; Frank Kozielski
Journal:  J Biol Chem       Date:  2006-02-28       Impact factor: 5.157

Review 6.  On the road to cancer: aneuploidy and the mitotic checkpoint.

Authors:  Geert J P L Kops; Beth A A Weaver; Don W Cleveland
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

Review 7.  Microcephaly is not mandatory for the diagnosis of mosaic variegated aneuploidy syndrome.

Authors:  P Callier; L Faivre; V Cusin; N Marle; C Thauvin-Robinet; D Sandre; T Rousseau; P Sagot; E Lacombe; V Faber; F Mugneret
Journal:  Am J Med Genet A       Date:  2005-08-30       Impact factor: 2.802

8.  Mad3p, a pseudosubstrate inhibitor of APCCdc20 in the spindle assembly checkpoint.

Authors:  Janet L Burton; Mark J Solomon
Journal:  Genes Dev       Date:  2007-03-15       Impact factor: 11.361

9.  Mad3 KEN boxes mediate both Cdc20 and Mad3 turnover, and are critical for the spindle checkpoint.

Authors:  Emma M J King; Sjaak J A van der Sar; Kevin G Hardwick
Journal:  PLoS One       Date:  2007-04-04       Impact factor: 3.240

10.  Human BUBR1 is a mitotic checkpoint kinase that monitors CENP-E functions at kinetochores and binds the cyclosome/APC.

Authors:  G K Chan; S A Jablonski; V Sudakin; J C Hittle; T J Yen
Journal:  J Cell Biol       Date:  1999-09-06       Impact factor: 10.539

View more
  48 in total

1.  BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy.

Authors:  Dominik Schnerch; Andrea Schmidts; Marie Follo; Josefina Udi; Julia Felthaus; Dietmar Pfeifer; Monika Engelhardt; Ralph Wäsch
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

Review 2.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

Review 3.  Bub1 and BubR1: at the interface between chromosome attachment and the spindle checkpoint.

Authors:  Sabine Elowe
Journal:  Mol Cell Biol       Date:  2011-05-31       Impact factor: 4.272

4.  BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome.

Authors:  Cynthia J Sieben; Karthik B Jeganathan; Grace G Nelson; Ines Sturmlechner; Cheng Zhang; Willemijn H van Deursen; Bjorn Bakker; Floris Foijer; Hu Li; Darren J Baker; Jan M van Deursen
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

5.  BUB1B promotes multiple myeloma cell proliferation through CDC20/CCNB axis.

Authors:  Ye Yang; Chunyan Gu; Chen Luo; Fei Li; Min Wang
Journal:  Med Oncol       Date:  2015-02-20       Impact factor: 3.064

6.  Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program.

Authors:  Richard B Lock; Hernan Carol; Christopher L Morton; Stephen T Keir; C Patrick Reynolds; Min H Kang; John M Maris; Amy W Wozniak; Richard Gorlick; E Anders Kolb; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2011-05-16       Impact factor: 3.167

Review 7.  Playing polo during mitosis: PLK1 takes the lead.

Authors:  G Combes; I Alharbi; L G Braga; S Elowe
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

8.  Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.

Authors:  Xiaolin Wan; Choh Yeung; Su Young Kim; Joseph G Dolan; Vu N Ngo; Sandra Burkett; Javed Khan; Louis M Staudt; Lee J Helman
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

9.  Observing Mitotic Division and Dynamics in a Live Zebrafish Embryo.

Authors:  Stefanie M Percival; John M Parant
Journal:  J Vis Exp       Date:  2016-07-15       Impact factor: 1.355

10.  p21 both attenuates and drives senescence and aging in BubR1 progeroid mice.

Authors:  Darren J Baker; Robbyn L Weaver; Jan M van Deursen
Journal:  Cell Rep       Date:  2013-04-18       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.